High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form of tuberculosis causes inflammation of the brain membranes, and half of the patients die. These findings come…

Continue Reading

News Source: medicalxpress.com